1 / 18

Treatment Options for Post-MI patients with LVD – are all ACE Inhibitors Equal?

This program provides an overview of treatment options for post-myocardial infarction (MI) patients with left ventricular dysfunction (LVD). It explores the influence of LV dysfunction on post-MI outcomes, the predictive value of markers of organ damage, and the targeting of neurohormonal pathways. The ESC guideline recommendations and distinguishing between agents in the same class are discussed. The program also covers the cardioprotective effects of Zofenopril and the effects of ACE inhibitors on endothelial stress. SMILE-4, a subanalysis focusing on ACE inhibitors in combination with aspirin, and SMILE-ISCHEMIA, analyzing patients with preserved LV function, are included. Conclusions and abbreviations are provided.

Download Presentation

Treatment Options for Post-MI patients with LVD – are all ACE Inhibitors Equal?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

More Related